Last updated: July 12, 2026

Application No. 19/338,733

Untitled Application

Unknown

Filed

Priority

Sep 25, 2024 — provisional 63/698,705

Examiner

WHITE, DAWANNA SHAR-DAY

Art Unit

Tech Center

Nacuity Pharmaceuticals, Inc.

Assignee

Nacuity Pharmaceuticals Inc.

OA Round

1 (Non-Final)

This examiner grants 62% of cases after interview

— +24.1% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 109 resolved cases, 2023–2026

Examiner Intelligence

WHITE, DAWANNA SHAR-DAY View full profile →

Grants 62% of resolved cases

Career Allowance Rate

68 granted / 109 resolved

+2.4% vs TC avg

Strong +24% interview lift

Without

With

+24.1%

Interview Lift

resolved cases with interview

Typical timeline

3y 5m

Avg Prosecution

52 currently pending

Career history

157

Total Applications

across all art units

Statute-Specific Performance

§101

2.8%

-37.2% vs TC avg

§103

32.2%

-7.8% vs TC avg

§102

5.4%

-34.6% vs TC avg

§112

8.2%

-31.8% vs TC avg

Black line = Tech Center average estimate • Based on career data from 109 resolved cases

Prosecution Timeline

Jun 02, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/886,990

Patent 12667571

Uridine Phosphorylase (UPase) Inhibitors for Treatment of Liver Conditions

3y 10m to grant Granted Jun 30, 2026

17/997,531

Patent 12617773

AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS

3y 6m to grant Granted May 05, 2026

17/715,463

Patent 12606555

CHEMICAL COMPOUNDS

4y 0m to grant Granted Apr 21, 2026

17/581,010

Patent 12600725

SELECTIVE GRP94 INHIBITORS AND USES THEREOF

4y 2m to grant Granted Apr 14, 2026

17/417,309

Patent 12582646

METHOD FOR TREATING DRUG OR ALCOHOL DEPENDENCY

4y 9m to grant Granted Mar 24, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

62%

Grant Probability

86%

With Interview (+24.1%)

3y 5m

Median Time to Grant

Low

PTA Risk

Based on 109 resolved cases by this examiner. Grant probability derived from career allowance rate.